Skip to content
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
Keytruda
Dr. Robert J. Motzer on the survival benefit of pembrolizumab / lenvatinib in the RCC front line
ASCO GU: Merck, Eisai turn up the heat in kidney cancer with Keytruda-Lenvima survival data
Pembrolizumab / Ipilimumab Combo does not improve survival, showing higher toxicity in PD-L1 + NSCLC